Norstella
Citeline Podcasts
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
Vizitează neapărat site-ul podcastului și susține-i creatorul: www.citeline.com
Autor
Norstella
Categorie
Site-ul podcastului
Cel mai nou episod
19 nov. 2026
Unde asculți?
Podcasturi în aplicație Replaio Radio În curândPodcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor
Episoade
Lupin’s CEO And MD On GLP-1 Strategy, Business Growth And Legacy 26.03.2026 41:45
Lupin’s CEO Vinita Gupta and managing director Nilesh Gupta speak with Citeline’s senior editor Vibha Ravi about their plans for first-in-class and best-in-class assets including GLP-1 receptor agonists, the defining influence of their father D B Gupta on them, as well as the company’s ethos and future growth strategy.
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.23, 2026 23.03.2026 17:00
本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年3月20日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 今年将有众多重磅药物失去市场主导地位; 司美格鲁肽在印度的命运;跨国药企不再满足于单纯的中国授权; Almirall瞄准中国皮肤科资产;欧盟被敦促恢复生物制药竞争力。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-...
Scrip's Five Must-Know Things - Mar.23, 2026 23.03.2026 15:53
Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.13, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time – many blockbusters to fade this year: semaglutide’s India reckoning; multinationals look beyond simple China licensing; Almirall eyes China dermatology assets; EU urged to restore biopharma compe...
Drug Fix: ACIP Next Steps After Judge Stops Work, Potential Opioid Disposal Changes 20.03.2026 33:25
Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, and Editor-in-Chief Nielsen Hobbs discuss the next steps after a federal judge ruled the reconstitution of the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP), as well as recent changes to the childhood vaccine schedule, likely violated the law (:32). They also consid...
How a CDMO Created a Custom Vaccine Development Project 19.03.2026 15:43
What does it take to move from concept to commercial vaccine manufacturing at speed without compromising quality or compliance? In this conversation, leaders from Alfasigma’s CDMO arm, Morpho, share a detailed look at how they approached a complex vaccine technology transfer, from facility upgrades to regulatory approval. The discussion offers a grounded perspective on execution, coordination, and...
뇌질환 신약 개발 펀딩 부활 조짐 (Korean-language podcast) Mar.19, 2026 19.03.2026 3:20
최근 미국의 BIO 투자자 및 성장 서밋에서 투자자들은 초기 단계 신경과학 분야의 자금 조달 환경이 여전히 어렵지만, 이 분야에 대한 관심이 높아지고 있다는 징후가 보인다고 말했습니다. Scrip이 취재한 내용을 요약했습니다. AI 기반 텍스트 음성 변환 및 음성 모방 도구의 도움을 받아 제작되었습니다. Story link: https://insights.citeline.com/scrip/business/financing/neuroscience-drug-development-funding-poised-fo...
The Generics Bulletin Podcast: 2026 Conferences 17.03.2026 16:05
The final week of February saw the AAM hold its Access! 2026 annual conference in Miami and Medicines for Europe hold its annual regulatory and scientific affairs conference in Amsterdam. Generics Bulletin was there at both events and our reporters discuss the key takeaways in our latest podcast.
Winning In The Probiotics Space, With David Pineda Ereño 16.03.2026 29:53
Probiotics remain one of the fastest‑growing segments in consumer health, but companies still face the challenge of operating in a fragmented claims environment, building credible brands, and communicating benefits to increasingly savvy consumers. In part two of HBW Insight’s interview with probiotics expert, David Pineda Ereno, we explore how leading players are finding ways through this complexi...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.16, 2026 16.03.2026 15:32
本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年3月13日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 罗氏的吉雷德斯特兰特(giredestrant)III期试验遭遇挫折;BioNTech创始人退出公司; 伊普森将撤回Tazverik;拜耳面临困境;以及UCB的Bimzelx再获利好。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips...
Scrip's Five Must-Know Things - Mar.16, 2026 16.03.2026 14:00
Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.13, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time – Roche faces giredestrant Phase III setback; founders exit BioNTech; Ipsen to withdraw Tazverik; tough times for Bayer; and another boost for UCB’s Bimzelx. Story links: https://insights.citeline...
Drug Fix: US FDA’s Prasad Leaves, Harry Potter, And Is CNPV Effective Because Of RTOR? 13.03.2026 33:45
Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman and Editor-in-Chief Nielsen Hobbs discuss potential directions for the US Food and Drug Administration’s Center for Biologics Evaluation and Research after the departure of Director Vinay Prasad (:32), including similarities between the center’s leadership issues and the staffing problems in the Harry Potter saga’s Hogw...
Killing Cancer Loudly: Onchilles Pharma's Neutrophil-Derived Path to Pan-Cancer Therapy 11.03.2026 27:39
What if a drug could kill cancer cells broadly, spare the immune system and then train it to keep fighting, without triggering resistance? That's the promise behind the ELANE pathway, a mechanism discovered not from a hypothesis but from studying fundamental biology in patients. In this episode of the In Vivo Podcast, Court Turner, CEO and co-founder of Onchilles Pharma, and Lev Becker, CSO and sc...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar.9, 2026 09.03.2026 15:56
本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年3月6日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 中小型企业考虑在最惠国待遇下拓展欧洲市场;辉瑞CEO谈FDA疫苗审批决策;人工智能时代大型药企对CRDMOs有何期待;神经科学研究资金蓄势复苏;优时比与中国达成重大合作。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quic...
Scrip's Five Must-Know Things - Mar.9, 2026 09.03.2026 16:01
Audio roundup of selected biopharma industry content from Scrip over the business week ended Mar.6, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time – smaller companies consider European expansion under MFN; Pfizer CEO on FDA vaccine decisions; what does big pharma want from CRDMOs in AI age; neuroscience funding poised for comeback; and UCB’s...
Drug Fix: The State Of Facility Inspections With Two Former Senior US FDA Execs 06.03.2026 49:29
Pink Sheet Executive Editor Derrick Gingery and Senior Editor Sue Sutter are joined by special guests Michael Rogers, former US Food and Drug Administration associate commissioner for inspections and investigations, and Douglas Stearn, former principal deputy associate commissioner in the FDA Office of Inspections and Investigations, both now at Canal Row Advisors. They talk about the current stat...
Unpacking Europe’s Probiotic Rules with David Pineda Ereño 02.03.2026 25:40
The European market for probiotic dietary supplements is one of the most dynamic, but also one of the most complicated, areas of self‑care right now. Probiotics are hugely popular with consumers, widely used across Europe, and backed by an expanding body of science. But for companies trying to bring these products to market, one major obstacle remains: the European Union’s fragmented and highly re...
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Mar. 2, 2026 02.03.2026 15:50
本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年3月2日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: Zealand首席执行官呼吁终结减肥竞赛;默沙东谈人工智能辅助研发管线;布鲁斯·莱文的CAR-T疗法故事;生物制药并购活动回暖;2025年美国IPO市场艰难。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five...
Scrip's Five Must-Know Things - Mar.2, 2026 02.03.2026 16:17
Audio roundup of selected biopharma industry content from Scrip over the business week ended Feb.27, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time – Zealand CEO calls for end to weight loss Olympics; MSD on AI-assisted pipelines; Bruce Levine’s CAR-T stories; biopharma dealmaking bounces back; and 2025 was a tough year for US IPOs. Story lin...
Drug Fix: State Of The Generics Industry, US FDA Commissioner On Compassionate Use 27.02.2026 28:06
Pink Sheet Executive Editor Derrick Gingery, Editor-in-Chief Nielsen Hobbs and special guest Dave Wallace, executive editor of Generics Bulletin, discuss the generic industry’s future direction and priorities (:27) and the impact of recent policy moves on the biosimilar industry (12:28) following their trade association’s annual meeting, as well as US Food and Drug Administration Commissioner Mart...
Affibody and the Case for Antibody Mimetics in Radioligand Therapy 25.02.2026 26:25
Swedish biotech Affibody has spent over two decades engineering proteins 1/20th the size of a conventional monoclonal antibody — and CEO David Bejker believes they're perfectly suited to solve one of radioligand therapy's biggest problems: a dangerously narrow target space. Bejker discusses how Affibody's platform combines the selectivity of antibodies with the biodistribution flexibility of small...
글로벌 제약업계, 2026년 역풍 직면…최혜국 약가정책 영향은 제한적 (Korean-language podcast) Feb.25, 2026 25.02.2026 3:44
특허 만료와 미국 내 약가 압박은 대형 글로벌 제약사들이 극복해야 할 과제이며, 다수 제약사가 올해 소폭의 실적 상승을 전망하고 있다는 Scrip 기사를 요약한 내용입니다. https://insights.citeline.com/scrip/drug-pricing/drug-makers-confront-headwinds-in-2026-but-mfn-doesnt-seem-like-a-big-one-YYQBO72NSNCHBE6EBPKF2GSDB4/ Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) Feb. 24, 2026 24.02.2026 16:34
本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年2月20日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。 本期要闻: 哈德森在赛诺菲的遗产;特朗普推动美国制药投资背后的现实;拜耳的精准医疗战略与增长;今年值得关注的临床试验;以及Scrip关于人工智能与运营卓越的专题访谈。 Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen...
Scrip's Five Must-Know Things - Feb.24, 2026 24.02.2026 16:42
Audio roundup of selected biopharma industry content from Scrip over the business week ended February 20, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools. This time – Hudson’s legacy at Sanofi; the realities behind Trump’s US pharma investment push; Bayer’s precision medicine approach and growth; clinical trials to look out for this year; and Scrip Asks...
Drug Fix: ‘America First’ US FDA User Fees, Moderna’s Flu Vaccine Saga Continues 20.02.2026 31:06
Pink Sheet Executive Editor Derrick Gingery, Managing Editor Bridget Silverman, Senior Editor Sue Sutter, and Editor-in-Chief Nielsen Hobbs discuss a series of US Food and Drug Administration proposals for user fee program changes that would advance President Trump’s priorities and the concerns they raise (:31). They also consider the impact of the agency’s decision to review Moderna’s mRNA flu va...
Hansa Biopharma On Clearing The Path To Kidney Transplant 16.02.2026 37:45
Renée Aguiar-Lucander, CEO of Hansa Biopharma, discussed the company’s leading asset, its journey toward US FDA approval and the trials and tribulations of completing a Phase III program.
Podcasturi asemănătoare
Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice